These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27624779)

  • 1. Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells.
    Pallett MA; Crepin VF; Serafini N; Habibzay M; Kotik O; Sanchez-Garrido J; Di Santo JP; Shenoy AR; Berger CN; Frankel G
    Mucosal Immunol; 2017 May; 10(3):602-612. PubMed ID: 27624779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.
    Girard F; Crepin VF; Frankel G
    Infect Immun; 2009 Apr; 77(4):1304-14. PubMed ID: 19188355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
    Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
    Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli.
    Pollock GL; Oates CVL; Giogha C; Wong Fok Lung T; Ong SY; Pearson JS; Hartland EL
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.
    Silberger DJ; Zindl CL; Weaver CT
    Mucosal Immunol; 2017 Sep; 10(5):1108-1117. PubMed ID: 28612839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium.
    Khan MA; Bouzari S; Ma C; Rosenberger CM; Bergstrom KS; Gibson DL; Steiner TS; Vallance BA
    Infect Immun; 2008 Apr; 76(4):1410-22. PubMed ID: 18227166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A type III effector antagonizes death receptor signalling during bacterial gut infection.
    Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL
    Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Type III Effector NleF from EHEC Inhibits Epithelial Inflammatory Cell Death by Targeting Caspase-4.
    Song T; Li K; Zhou W; Zhou J; Jin Y; Dai H; Xu T; Hu M; Ren H; Yue J; Liang L
    Biomed Res Int; 2017; 2017():4101745. PubMed ID: 28593173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.
    Pallett MA; Berger CN; Pearson JS; Hartland EL; Frankel G
    Infect Immun; 2014 Nov; 82(11):4878-88. PubMed ID: 25183730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses.
    Berger CN; Crepin VF; Roumeliotis TI; Wright JC; Serafini N; Pevsner-Fischer M; Yu L; Elinav E; Di Santo JP; Choudhary JS; Frankel G
    PLoS Pathog; 2018 Oct; 14(10):e1007406. PubMed ID: 30365535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking Pathogen Virulence, Host Immunity and The Microbiota at the Intestinal Barrier.
    Nunez G
    Keio J Med; 2017; 66(1):14. PubMed ID: 28356548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens.
    Knodler LA; Crowley SM; Sham HP; Yang H; Wrande M; Ma C; Ernst RK; Steele-Mortimer O; Celli J; Vallance BA
    Cell Host Microbe; 2014 Aug; 16(2):249-256. PubMed ID: 25121752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.
    Wong Fok Lung T; Giogha C; Creuzburg K; Ong SY; Pollock GL; Zhang Y; Fung KY; Pearson JS; Hartland EL
    Infect Immun; 2016 May; 84(5):1346-1360. PubMed ID: 26883593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal epithelial CD98 directly modulates the innate host response to enteric bacterial pathogens.
    Charania MA; Laroui H; Liu H; Viennois E; Ayyadurai S; Xiao B; Ingersoll SA; Kalman D; Merlin D
    Infect Immun; 2013 Mar; 81(3):923-34. PubMed ID: 23297381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
    Thanabalasuriar A; Kim J; Gruenheid S
    Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attaching and effacing pathogens: the effector ABC of immune subversion.
    Riebisch AK; Mühlen S
    Future Microbiol; 2020 Jul; 15():945-958. PubMed ID: 32716209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the NleF effector protein from attaching and effacing bacterial pathogens.
    Echtenkamp F; Deng W; Wickham ME; Vazquez A; Puente JL; Thanabalasuriar A; Gruenheid S; Finlay BB; Hardwidge PR
    FEMS Microbiol Lett; 2008 Apr; 281(1):98-107. PubMed ID: 18279332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
    Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL
    J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity restricts Citrobacter rodentium A/E pathogenesis initiation to an early window of opportunity.
    Buschor S; Cuenca M; Uster SS; Schären OP; Balmer ML; Terrazos MA; Schürch CM; Hapfelmeier S
    PLoS Pathog; 2017 Jun; 13(6):e1006476. PubMed ID: 28662171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen.
    Spehlmann ME; Dann SM; Hruz P; Hanson E; McCole DF; Eckmann L
    J Immunol; 2009 Sep; 183(5):3332-43. PubMed ID: 19675161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.